🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/03/1980 | 1,66 | 1,68 | 1,66 | 1,68 | +2,23% | 1,20% | 5.738.429 |
| 10/03/1980 | 1,60 | 1,64 | 1,59 | 1,64 | +2,48% | 3,11% | 3.968.986 |
| 07/03/1980 | 1,56 | 1,61 | 1,56 | 1,60 | +2,77% | 3,40% | 4.761.274 |
| 06/03/1980 | 1,58 | 1,58 | 1,54 | 1,56 | -2,08% | 2,51% | 5.696.928 |
| 05/03/1980 | 1,62 | 1,63 | 1,59 | 1,59 | -1,64% | 2,46% | 4.972.550 |
| 04/03/1980 | 1,63 | 1,63 | 1,60 | 1,62 | -2,01% | 1,63% | 4.489.632 |
| 03/03/1980 | 1,68 | 1,69 | 1,64 | 1,65 | -1,77% | 2,96% | 2.799.418 |
| 29/02/1980 | 1,62 | 1,68 | 1,62 | 1,68 | +4,54% | 3,47% | 4.127.443 |
| 28/02/1980 | 1,64 | 1,67 | 1,60 | 1,61 | -2,22% | 4,23% | 3.904.848 |
| 27/02/1980 | 1,70 | 1,70 | 1,64 | 1,64 | -3,32% | 3,71% | 4.806.547 |
| 26/02/1980 | 1,72 | 1,72 | 1,68 | 1,70 | -1,35% | 1,93% | 3.414.384 |
| 25/02/1980 | 1,72 | 1,72 | 1,70 | 1,72 | -0,38% | 1,16% | 2.663.597 |
| 22/02/1980 | 1,72 | 1,75 | 1,72 | 1,73 | +0,38% | 1,74% | 5.368.694 |
| 21/02/1980 | 1,78 | 1,80 | 1,71 | 1,72 | -3,34% | 5,02% | 3.418.157 |
| 20/02/1980 | 1,72 | 1,78 | 1,72 | 1,78 | +3,86% | 3,86% | 3.101.242 |
| 19/02/1980 | 1,74 | 1,74 | 1,72 | 1,72 | -1,52% | 1,52% | 2.414.592 |
| 15/02/1980 | 1,77 | 1,77 | 1,74 | 1,74 | -1,87% | 1,87% | 2.754.144 |
| 14/02/1980 | 1,78 | 1,80 | 1,76 | 1,78 | -0,19% | 2,24% | 2.063.722 |
| 13/02/1980 | 1,83 | 1,83 | 1,78 | 1,78 | -2,72% | 2,90% | 2.988.058 |
| 12/02/1980 | 1,78 | 1,83 | 1,78 | 1,83 | +2,60% | 2,97% | 2.191.997 |
| 11/02/1980 | 1,75 | 1,78 | 1,75 | 1,78 | +1,89% | 1,89% | 3.203.107 |
| 08/02/1980 | 1,76 | 1,80 | 1,74 | 1,75 | -0,56% | 3,39% | 5.549.789 |
| 07/02/1980 | 1,81 | 1,81 | 1,76 | 1,76 | -2,75% | 2,93% | 4.278.355 |
| 06/02/1980 | 1,81 | 1,84 | 1,79 | 1,81 | -0,18% | 2,56% | 4.508.496 |
| 05/02/1980 | 1,81 | 1,83 | 1,81 | 1,81 | +0,18% | 1,10% | 3.406.838 |
| 04/02/1980 | 1,80 | 1,81 | 1,80 | 1,81 | +0,93% | 0,74% | 2.840.918 |
| 01/02/1980 | 1,81 | 1,81 | 1,77 | 1,79 | -1,28% | 2,20% | 3.648.298 |
| 31/01/1980 | 1,85 | 1,87 | 1,82 | 1,82 | -1,80% | 2,87% | 2.373.091 |
| 30/01/1980 | 1,83 | 1,85 | 1,82 | 1,85 | +1,27% | 1,82% | 1.795.853 |
| 29/01/1980 | 1,84 | 1,84 | 1,81 | 1,83 | -1,07% | 1,80% | 2.701.325 |